Approaches to Reduce Therapeutic Inertia in Diabetes Management
A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
Hyperglycemia
Considerations for Treatment of Endocrine Dysfunction in COVID-19
Review authors summarized preliminary research on COVID-19 and past research on SARS-CoV-1 regarding their relationship with endocrine dysfunction.
Hyperglycemia Linked to Higher Mortality in COVID-19 Patients
For COVID-19 patients without a previous diagnosis of diabetes, fasting blood glucose (FBG) ≥7.0 mmol/L is an independent predictor of 28-day mortality.
Hyperglycemia and COVID-19: Why Management of Glucose Levels Is Essential
Hyperglycemia may worsen outcomes in COVID-19 due to a rapid inflammatory response and increased glycosylation of the ACE2 receptor.
Comorbid Diabetes, Schizophrenia Increase Hyperglycemic Episode Risk
Findings showed a higher incidence of hyperglycemic episodes in patients with diabetes and comorbid schizophrenia than in those without schizophrenia.
Hyperglycemia in Pregnancy May Up Risk for Obesity in Offspring
Children of obese women with gestational diabetes have increased risk for childhood obesity.
Hyperglycemia During Pregnancy May Affect Childhood Glucose and Insulin Resistance in Offspring
Maternal glycemia during pregnancy may influence childhood glucose and insulin resistance regardless of BMI and family history of diabetes.
Transplant, steroids, and diabetes: Inpatient and outpatient management
A patient, aged 60 years, was admitted to the hospital to undergo renal transplant therapy. He had a history of type 2 diabetes for 15 years.
Transitioning a patient with a complex insulin regimen from hospital to home
When creating outpatient diabetes management plan, the patient’s inpatient medication regimen should be considered but not necessarily replicated.
Updated recommendations for managing hyperglycemia in type 2 diabetes
In 2012, the ADA and the EASD published a position statement on the management of hyperglycemia in patients with T2DM. In January, 2015, the ADA and EASD issued an update to the original 2012 statement.
- Loading...
Loading...
Loading... 
Loading...